Appeal No. 1997-1705
Application 08/211,352
claims remaining in the application.
THE INVENTION
Appellant’s claimed invention is directed toward a method
for treating a juvenile patient up to six years in age who
suffers from muscle contractures due to cerebral palsy.
Claims 1 and 17 are illustrative and read as follows:
1. A method for treating a juvenile patient, said method
comprising formulating a solution containing a presynaptic
neurotoxin for the promotion of normal muscle growth in a
juvenile patient of up to six years in age, suffering from
dynamic contractures due to cerebral palsy, said promotion
having a duration greater than a clinical activity of said
presynaptic neurotoxin, and administering said formulation to
said juvenile patient.
17. A method for causing relief of muscle contractures
due to cerebral palsy in juvenile patients, said method
comprising the administering to a juvenile patient of up to
six years in age an effective amount of botulinum toxin A
having clinical activity for blocking the release of synaptic
vesicles containing acetylcholine, the relief from arrested
muscle growth having a duration greater than the clinical
activity of the presynaptic neurotoxin.[1]
THE REFERENCES
T.K. Das & D.M. Park (Das), “Effect of treatment with
botulinum toxin on spasticity”, 65 Postgrad. Med. J. 208-10
1 In the event of further prosecution, appellant and the
examiner should address on the record whether the antecedent
basis in claim 17 for “the presynaptic neurotoxin” is
sufficiently clear.
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: November 3, 2007